NCT05625724: Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
- State
- Under way
- Phase
- Phase 3
- People
- 1,164 planned
- Started
- 2 Aug 2023
- Primary completion
- Aug 2028
- Arms
- Aspirin
- Results
- None posted
- 23 Nov 2022: Trial registered
- 2 Aug 2023: Trial started